Comparative Evaluation of Therapeutic Efficacy and Safety of Intralesional Triamcinolone Acetonide Alone Versus Modified Intralesional Radiofrequency with Triamcinolone Acetonide in The Treatment of Keloids
Keywords:
Keloids, Triamcinolone acetonide, Modified Intralesional Radiofrequency, POSASAbstract
Background: Keloids are fibroproliferative disorders resulting from an aberrant wound-healing process. They are notorious for their resistance to conventional treatments and their tendency to recur. While intralesional corticosteroids remain a mainstay in treatment, newer combination techniques are being investigated to enhance outcomes.
Objective: To compare the therapeutic efficacy and safety of intralesional triamcinolone acetonide (TAC) monotherapy versus modified intralesional radiofrequency (mRF) with TAC injection in patients with keloids.
Materials and Methods: A prospective comparative study was conducted between 1st May 2024 to 31st October 2024. Thirty patients with keloids were enrolled and randomized into two equal groups: Group A received intralesional TAC (40 mg/mL), and Group B underwent a modified intralesional RF technique with TAC. Four treatment sessions were conducted at 4-week intervals, with outcomes evaluated by Patient and Observer Scar Assessment Scale (POSAS).
Results: Group B exhibited a greater reduction in POSAS scores 71.53% compared to Group A (65.32%). Group B also showed a more significant reduction in keloid size and technique was well tolerated in treatment of keloids.
Conclusion: Modified intralesional RF with TAC is a superior modality to TAC alone for treating keloids, offering better efficacy and safety with minimal complications.
Downloads
References
Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117(1):286–300.
Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: A comprehensive review. Plast Reconstr Surg. 1989;84(5):827–837.
Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: The paradigm of skin fibrosis—Pathomechanisms and treatment. Matrix Biol. 2016;51:37–46.
Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: Pathophysiology, classification, and treatment. Dermatol Surg. 2017;43 Suppl 1:S3–S18.
Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17(1-2):113–125.
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg. 2010;125(2):557–568.
Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 585-nm pulsed dye laser, and combined treatment. Arch Dermatol. 2002;138(9):1149–1155.
Berman B, Bieley HC. Adjunct therapies to corticosteroids in the treatment of keloids and hypertrophic scars. Dermatol Surg. 1996;22(2):126–130.
Elsaie ML, Kamal R. Radiofrequency in dermatology. Indian J Dermatol. 2009;54(2):100–105.
Gupta S, Kalra A. Efficacy and safety of intralesional radiofrequency ablation for the treatment of keloids: A pilot study. J Cutan Aesthet Surg. 2015;8(3):162–166.
Taneja N, Ahuja R, Gupta S. Modified technique of intralesional radiofrequency with drug deposition in keloids using customized intravenous cannulas. J Am Acad Dermatol. 2023 Aug;89(2):e89-e90. doi: 10.1016/j.jaad.2021.05.037. Epub 2021 May 29. PMID: 34058277.
Kaushal V, Kumar S, Brar BK, Singh A. Comparative evaluation of therapeutic efficacy and safety of intralesional triamcinolone acetonide injection vs intralesional radiofrequency with intralesional triamcinolone acetonide in treatment of keloids. Dermatol Ther. 2020 Nov;33(6):e13919. doi: 10.1111/dth.13919. Epub 2020 Jul 29. PMID: 32594600
..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
